Release and scope verification
Map installed build, options, population, anatomy, inputs, outputs, and enabled functions to K251059.
exact submission · checked 2026-09-04FDA-cleared profile
Syngo Carbon Clinicals (VA41)
Siemens Healthineers AG
Syngo Carbon Clinicals VA41 provides advanced visualization and analysis for clinical images, including OrthoMatic Spine whole-spine curve-angle measurements and TimeLens comparison of regions of interest across time points.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
- Exact purpose
- Syngo Carbon Clinicals VA41 provides advanced visualization and analysis for clinical images, including OrthoMatic Spine whole-spine curve-angle measurements and TimeLens comparison of regions of interest across time points.
- Intended users
- Technicians and physicians.
- Care setting and population
- Clinical imaging workstations using compatible SYNGO host applications.
- Workflow role
- Image visualization, quantitative measurement, longitudinal comparison, and clinical communication support.
- Required input
- Clinical image data from supported CT, MR, and other connected imaging workflows through SYNGO host applications.
- Output and human action
- Rendered views, spine measurements, time-point comparisons, and communicated or stored clinical-image results.
- Limitations
- Available functions depend on the licensed subset, SYNGO host application, supported modality, acquisition, and user review. The software provides visualization and measurements, not an autonomous diagnosis.
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
- FDA submission
- K251059
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Whole spine and other clinical image regions represented in supported CT and MR workflows
- Clearance type
- 510(k)
- Decision date
- 2025-10-24
- FDA status
- FDA-cleared
Implementation
Questions for IT, informatics, and operations
Use these fields to structure a vendor demo, security review, and implementation estimate.
- Integration
- The FDA package describes a software plug-in called by standard interfaces from SYNGO host applications such as Syngo Carbon Space and syngo.via, with results returned to the host workflow.
- Deployment and data flow
- The FDA package describes a dedicated workstation and compatible SYNGO host applications; current deployment topology, hosting, security, and site configuration remain unknown.
- Security and privacy
- Not established in reviewed sources
Public materials reviewed for this exact submission do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Training and support
- Use by technicians and physicians. Follow the exact labeling, local training, supervision, and escalation requirements.
- Monitoring and change control
- Monitor labeled population, acquisition quality, exclusions, reviewer overrides, failures, and downstream workflow effects for K251059.
Deployment boundary
The FDA package describes a dedicated workstation and compatible SYNGO host applications; current deployment topology, hosting, security, and site configuration remain unknown.
exact submission · checked 2026-09-04Interoperability acceptance
The FDA package describes a software plug-in called by standard interfaces from SYNGO host applications such as Syngo Carbon Space and syngo.via, with results returned to the host workflow.
exact submission · checked 2026-09-04Clinical acceptance
Test labeled population, acquisition quality, exclusions, failed inputs, reviewer overrides, and downstream effects for K251059.
exact submission · checked 2026-09-04Economic evaluation
Exact-product price, implementation cost, reimbursement, and total-cost evidence remain to be obtained; do not infer them from FDA clearance.
product family · checked 2026-09-04Lifecycle monitoring
Monitor labeling, software version, complaints, recalls, failed inputs, overrides, and postmarket signals against the exact submission and installed configuration.
exact submission · checked 2026-09-04Evidence
Performance evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
- Evidence summary
- K251059 FDA decision material establishes the labeled use, workflow, inputs, outputs, and limitations for Syngo Carbon Clinicals VA41. No exact-submission clinical performance metric is promoted without a complete source table and version-scoped endpoint.
- Reported sensitivity
- Not applicable
Do not generalize an endpoint across populations, thresholds, versions, or workflows; use only exact evidence.metrics records.
- Reported specificity
- Not applicable
Do not generalize an endpoint across populations, thresholds, versions, or workflows; use only exact evidence.metrics records.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K251059 FDA evidence package for Syngo Carbon Clinicals (VA41)
FDA 510(k) decision evidence and product verification for the exact submission. · Whole spine and other clinical image regions represented in supported CT and MR workflows
exact submission · Tested version: Syngo Carbon Clinicals VA41 · Sponsor or vendor studyK251059
FDA-submitted evidence for the exact decision; it is not independent clinical validation and does not establish local production qualification.
Economics and lifecycle
Budget and ongoing governance
These are common procurement questions; unknown values remain visible until a source supports them.
- Pricing and total cost
- Not established in reviewed sources
No public list price or commercial contract for the exact submission and version was identified.
- Reimbursement and coding
- Not established in reviewed sources
No exact-product payer coverage or reimbursement determination was identified in reviewed public material.
No product-specific code
No exact-product reimbursement determination identified in reviewed public material
Centers for Medicare & Medicaid Services · United StatesThis public-policy review is not a coverage determination. Verify payer, site-of-service, coding, and local value assumptions independently.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
- Postmarket safety review
- No record matched K251059 by exact native submission identifier in the 2026-09-02 openFDA snapshot; this does not exclude product-family, later-version, or adverse-event information.
Buyer worksheet
Open questions to take to the vendor
- Verify security and privacy controls: Public materials reviewed for this exact submission do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
- Verify pricing and total cost: No public list price or commercial contract for the exact submission and version was identified.
- Verify reimbursement and coding relevance: No exact-product payer coverage or reimbursement determination was identified in reviewed public material.
Research record
What has been checked
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
10Source classes checked
0Reviewed PubMed leads
0Reviewed trial leads
0Unreviewed FDA recall leads
The snapshot contained no PubMed or ClinicalTrials.gov candidates; no evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Sources
Source ledger
Sources accessed through 2026-09-04.
- FDA 510(k) decision material K251059: Syngo Carbon Clinicals (VA41) U.S. Food and Drug Administration · 2026-09-04
- Artificial Intelligence-Enabled Medical Devices U.S. Food and Drug Administration · 2026-08-31
- PubMed biomedical literature index U.S. National Library of Medicine · 2026-09-01
- ClinicalTrials.gov study registry U.S. National Library of Medicine · 2026-09-01
- Medicare Coverage Database Centers for Medicare & Medicaid Services · 2026-09-01
- openFDA Device Recall API U.S. Food and Drug Administration · 2026-09-02
Alternatives
Related tools to compare
FDA-cleared K261289
UNiD™ Spine Analyzer (SW3002)
Medicrea International S.A.S. (Medtronic)
UNiD Spine Analyzer SW3002 v5.1.0 enables healthcare professionals to view and measure images and plan orthopedic spine surgeries, including preoperative and postoperative...
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Spine
- Decision
- 2026-05-15
FDA-cleared K251629
UNiD™ Spine Analyzer
Medicrea International S.A.S. (Medtronic)
UNiD Spine Analyzer assists healthcare professionals in viewing and measuring images and planning orthopedic spine surgery, including preoperative and postoperative measurements,...
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Spine
- Decision
- 2025-08-07
FDA-cleared K243647
Synapse PACS (7.5)
FUJIFILM Healthcare Americas Corporation
Synapse PACS version 7.5 provides primary processing and presentation of DICOM and supported non-DICOM images with measurement, segmentation, fusion, volume rendering, reporting,...
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Multi-region
- Decision
- 2025-06-30
FDA-cleared K231955
aprevo® Digital Segmentation
Carlsmed, Inc.
aprevo Digital Segmentation is software for trained, medically knowledgeable design personnel to perform digital image segmentation of the spine, primarily lumbar anatomy; it...
- Modality
- Radiological images; modality varies or is not specified in FDA list
- Anatomy
- Spine, primarily lumbar anatomy
- Decision
- 2023-11-03